USPTO serial 79190409
S SENSILE MEDICAL
Reviewed by CopyMark Law Group
Reg. 5253131Status 709
- Filing date
- Status date
- Registration date
- Aug 1, 2017
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with S SENSILE MEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Diane B Melnick
Diane B Melnick POWLEY & GIBSON P.C.304 Hudson St.Suite 202New York, NY 10013Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments, namely, blood glucose meters, devices for measuring glycerin; medical apparatus for analyzing blood and blood plasma; medical apparatus for extracting and analyzing blood; apparatus for diagnoses and for analyses for medical use, in particular glucose meters, devices for measuring blood sugar; medical apparatus for introducing pharmaceutical preparations into the human body, in particular apparatus for introducing insulin and/or glucagon, namely, medical syringes, insulin injectors sold empty, and insulin and glycogen pumps; pumps for medical use, in particular mobile and portable insulin pumps and insulin patch pumps; insulin pumps, diuretic pumps and antibiotic pumps, all for medical use; belts for medical use; injectors for medical use, namely, medical fluid injectors; pens for injecting insulin and glucagon sold empty; brush pens and dispensation devices in the form of pens, sold empty, for accurate, precise dosing and application of medical creams and preparations; medical test kits for diabetes control for clinical or household use | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, consumer product safety testing in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy equipment, scientific research in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy, design of diabetes, growth hormone deficiency, pain therapy, and chemotherapy monitoring equipment for others; scientific and technological services and research and design relating thereto, namely, scientific research and new product design services in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; technological advice in the field of design and development of technology for devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; scientific laboratory services; scientific services, namely, conducting of clinical trials for others in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; conducting of clinical trials for others in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps, all in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; industrial analysis and research services in the field of design of medical equipment for use in the management and treatment of diabetes, growth hormone deficiency, pain therapy, and chemotherapy related medical equipment; industrial analysis and research services in the field of devices for dispensing and applying medicines, medical preparations or creams, in particular pumps for medical use, injection pens, brush pens and dispensation devices in the form of pens, and patch pumps; bacteriological research services; biological research services; design and development of products in the field of fluids, mechanics, electronics and software; technical project study, namely, conducting scientific feasibility studies; research and development of new products for others; technical research services, namely, research in the field of diabetes, growth hormone deficiency, pain therapy, and chemotherapy monitoring technology; carrying out scientific feasibility studies; testing of materials; measuring services, namely, calibration; quality control for others; design and development of software; installation, maintenance and updating and rental of software; software consultancy; all of the foregoing services relating to the fields of diabetes, growth hormone deficiency, pain therapy, and chemotherapy | SECTION 71 - CANCELLED | — |
| 044 | Medical services, in particular in the field of care for diabetics; medical testing and analysis for diagnostic or treatment purposes in the fields of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; medical diagnosis of diseases, in particular diabetic diseases; pharmacy advice, namely, pharmaceutical advice; medical and pharmaceutical consultancy, particularly in the field of diabetes; medical equipment rental in the fields of diabetes, growth hormone deficiency, pain therapy, and chemotherapy; medical information, medical advice and medical consultancy, particularly relating to the treatment and care of diabetes; provision of educational information on diabetes via a website; provision of information on the use of medical diagnostic diabetes testing apparatus and consultancy in the field of medical diagnostics via a website | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sensile Pat AG
- Other trademarks owned by Sensile Pat AG
- Other trademarks owned by Sensile Medical AG
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named S SENSILE MEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 19, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 23, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 5, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 5, 2024 | INPC | INVALIDATION PROCESSED | — |
| Oct 17, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 16, 2024 | C71T | CANCELLED SECTION 71 | — |
| Oct 1, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 1, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 1, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 13, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 13, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 1, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 26, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 1, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 16, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 16, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 26, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 10, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 5, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 5, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 5, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 5, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 5, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 14, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 14, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 13, 2017 | ALIE | ASSIGNED TO LIE | — |
| Feb 27, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 29, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 29, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 27, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 26, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 19, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 18, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |